420 with CNW – Poll Shows Americans want CBD as an OTC Drug

A survey conducted by Gallup has found that the majority of Americans who are familiar with CBD (cannabidiol) want it available as an over-the-counter drug. The results of the survey were released on Friday last week (June 14).

The CBD craze traces its roots to the cannabis reform movement, and it gained momentum when the Farm Bill 2018 became law last year. This bill legalized industrial hemp and all its derivatives, including CBD.

The survey involving 1,017 participants was conducted over the phone in a bid to get insights into the widespread appeal of CBD. The interviews were conducted from May 15-30.

In all, 39 percent of the people polled revealed that they want to see CBD available as an OTC drug while 21 percent said CBD should be accessed using a doctor’s prescription. 36 percent of the people polled revealed that they weren’t familiar with this particular compound of hemp and marijuana plants.

When Gallup focused on those who were familiar with CBD and asked them whether CBD should be purchased as an OTC drug or as a prescription drug, 61 percent favored the OTC option while 33 percent preferred to see it as a prescription drug.

The participants in the poll were also asked to rate how familiar they were with CBD. 14 percent looked at themselves as “very familiar” with it, 33 percent felt they were “somewhat familiar”, 17 percent felt they were “not too familiar” while 36 percent confessed that they “weren’t familiar at all” with cannabidiol.

Gallup again narrowed its attention to only those who categorized themselves as very familiar with cannabidiol and asked them for their opinion about the medicinal value of CBD. 90 percent of this group believed that CBD had therapeutic benefits.

Of those who thought CBD had medicinal benefits, 33 percent said it had “a lot of benefits”, 45 percent felt CBD had “some benefits” and 14 percent thought cannabidiol had “a few benefits.” 3 percent were neutral on the matter while 4 percent said cannabidiol didn’t have any medical benefits.

Commenting about their findings, Gallup wrote that most Americans already believe that CBD has medicinal value even if research has been slow in proving or disproving many of the therapeutic benefits attributed to CBD. Gallup is convinced that the fraction of people who think CBD is medicinal is most likely to grow as more people get exposed to this non-psychoactive compound.

This possibility takes on a greater degree of certainty given that the FDA has already been convinced enough of CBD’s therapeutic benefits to the extent of approving a drug targeting rare forms of epilepsy.

The pressure on federal agencies like the FDA and Congress to pass laws legalizing CBD as a food supplement and other uses is therefore going to increase as the months go by.

Cannabis industry analysts are of the opinion that the Gallup findings didn’t catch industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) by surprise.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Congressional Report Raises Issues on Marijuana Impaired Driving

A Congressional research body has released a report whose findings bring into question a common assumption which has always been made by legislators that the legalization of marijuana leads to more accidents on roads due to impairment.

The experts, who were instructed by Senate and Congress to study the issue of impaired driving, didn’t find any conclusive evidence that marijuana can cause a driver to be impaired.

While law enforcement agencies have tried and true tools to identify people who are driving while impaired by alcohol, developing similar tools for dealing with marijuana driving impairment has proved to be very challenging.

The problem isn’t just the lack of appropriate technology. Additional questions also exist regarding how much THC can cause impairment and how that impairment is caused. The CRS (Congressional Research Service) writes in its report that while laboratory tests have proved that one can be impaired after consuming marijuana, conflicting results were found when studies were done to ascertain the degree of added risk of fatal crashes resulting from marijuana consumption.

Both opponents and advocates of legalizing marijuana agree that a lasting solution should be found to the issue of how to detect marijuana-impaired driving. However, the experts still doubt whether it will be possible to develop appropriate technology to detect impaired driving since what is currently available can only test whether someone has recently consumed cannabis.

It is remarkable that the Congressional report mentions several times that it isn’t clear cut that marijuana consumption is associated with a heightened risk of traffic accidents. This runs counter to the assumption which has been commonly held by Congress that when marijuana restrictions are loosened, there will be a rise in traffic accident fatalities.

This line of thinking also appeared in the wording of a recent House Appropriations Committee report in which funds were allocated to law enforcement agencies to identify drivers impaired by marijuana as a way of reducing the fatal accidents resulting from the increasing legalization of marijuana by states around the country.

Different researchers have reported that fatalities on the road don’t increase after marijuana has been legalized by a state. However, this doesn’t alter the reality that both sides on the marijuana legalization issue advise against driving after one has consumed cannabis.

The deputy director of NORML explained how hard it is to determine impairment from marijuana. He says that the effects on the psychomotor system are normally less acute and take a shorter time if one consumes marijuana, unlike the opposite case after alcohol consumption. Furthermore, THC remains detectable for a longer time, so a positive test doesn’t prove that one is impaired or consumed cannabis recently.

The Congressional researchers offer a number of recommendations on what Congress can do in light of the information gathered by the researchers. One recommendation is that more research should be done to determine whether a quantitative standard is feasible when determining cannabis impairment.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4), Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) welcomes the report of the Congressional Research Service because it helps to dispel some of the misconceptions about marijuana use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – 50 State Banking Associations Urge Congress to Act on Marijuana Banking

Banking associations from all the 50 states across the U.S. have written a letter to the Senate Banking Committee to pass and advance the bipartisan bill before it seeking to protect financial institutions from federal penalties for doing business with licensed marijuana businesses.

In their letter delivered on April 20, the state banking associations observed that forcing cannabis businesses to operate on a cash-only basis exposes the businesses, their employees and the public to serious safety risks.

The banking associations also added that regulation and enforcement has been very difficult, something that can have adverse effects on the economy. Tax collection becomes inefficient and expensive since modern methods of remitting payments cannot be used. Compliance audits also become expensive because there is no clear paper trail to follow when looking into the financial records of marijuana businesses.

The banking associations also complained that while the Congressional Financial Services Committee passed a similar bill in March, other committees haven’t acted on the companion bills since then.

In their letter, the banking associations were quick to point out that they are neither in favor of nor against the legalization of marijuana. Their sole purpose is to serve the communities in their areas, including jurisdictions which have opted to legalize marijuana.

They added that there are many legitimate concerns which have to be considered on the subject of marijuana, but they were calling on Congress to narrow their focus for now on the issue of the banking sector with respect to the marijuana industry while other broader issues on marijuana policy are debated.

The Chairman of the Senate Banking Committee, Sen. Mike Crapo, revealed that he wouldn’t commit himself to bringing the marijuana banking bill before his committee until the Department of Justice had pronounced itself on the matter.

However, the banking association from the senator’s own home state seems to disagree with him and signed the letter. The association of attorneys general also disagrees and sent their own letter urging federal action to be taken to ease marijuana banking.

The National Association of State Treasurers has also written a letter calling on Congress to enact legislation which will make it possible for the cannabis industry to receive basic banking services in the states where such businesses are legal and licensed. Their reasons mirror the reasons stated by the 50 banking associations from all the states in the country.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) look forward to the day when the federal government will listen to the voices of the different associations asking for enabling laws to allow cannabis businesses to thrive in the states where they are licensed to operate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Confident Cannabis Raises $12M for Nationwide Expansion

Confident Cannabis, a cannabis wholesale platform, has raised $12m to bring its total capitalization to more than $18m from their inception. The new funding is intended to enable the company to expand its operations into new territories across the country.

The Series A funding round was led by Poseidon Asset Management, a cannabis venture capital fund based in San Francisco. Other entities that invested more funds in Confident Cannabis include Y Combinator, Bullpen Capital, FJLabs as well as Greenfield Global and Base Ventures.

Confident Cannabis focuses on empowering all verticals within the cannabis industry so that all players, including cultivators and finally customers of cannabis end-products can know what is available in the industry, who makes it and what that specific product is made from. Confident Cannabis’ platform makes all this information available in real time, and the data they provide is verified by independent labs.

Last year in October, Confident Cannabis launched its platform, Wholesale, in Oregon. This meant that, for the first time, all players in the cannabis industry could interact with each other without having any fears about the authenticity or quality of the products showcased on the platform. The doubts were removed because Wholesale availed lab test results from licensed testing facilities.

Morgan Paxhia and Emily Paxhia, the two cofounders of Poseidon Asset Management, revealed that they decided to invest in Confident Cannabis after watching it closely from 2015 and seeing how far Confident Cannabis has come.

Emily Paxhia added that they were intrigued when all labs they encountered raved about how good the software provided by Confident Cannabis was. This was unexpected, because testing facilities rarely sing the praises of the software powering their systems. Poseidon Asset Management was hooked, and their participation in the Series A funding round is testament to their confidence in the future of Confident Cannabis.

Currently, more than 40 percent of all the marijuana which is produced legally within the U.S. passes through the lab testing platform run by Confident Cannabis. The expansion of their operations into more markets will avail that inventory of cannabis to more wholesalers, retailers and consumers.

All the entities that participated in this funding round praised Confident Cannabis for helping to increase compliance within the marijuana industry by providing solutions which address the current and future needs of the industry.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) wish Confident Cannabis all the best because what they are doing helps all other players in the industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Nevada Dragged to Court Over the Issuance of Marijuana Licenses

The growing discontent among companies that weren’t selected to receive one of the marijuana business licenses issued by the State of Nevada has grown to an extent of lawsuits being filed against the tax department.

A dozen companies have gone to court and want the state to be stopped from issuing more licenses until court decides whether the selection process was “capricious and violated the state constitution.”

A total of six lawsuits have been filed, all alleging that no one knows what criteria was used by the state when selecting the cannabis companies to grant a license and which applications to reject.

The hearings against the tax department largely stem from the second round of marijuana business licenses issued in December 2018.

The plaintiffs claim that the tax department arbitrarily selected 61 out of 462 applications for the expansion of the available businesses in the cannabis industry which is now approximately two years old in the state.

The 61 licenses were given for new laboratory, cultivation, manufacturing and dispensing facilities. The complainants also add that the process to award licenses worth millions of dollars in the cannabis industry ought to be transparent enough so that those who won know why they did and those who lost can believe that they lost fair and square.

The cases filed are set to start being heard in the course of this week. These cases come at a time when the state senate has passed a proposal to compel the tax department to release into the public domain cannabis taxpayer information that has up to now been regarded as confidential.

This proposal is now headed to Nevada’s Assembly for consideration. Once the proposal is enacted into law, the names of all the companies that applied for licenses, and all those that were selected would be released.

Gov. Steve Sisolak also agrees that something should be done about the grumbling against the licensing process, so he supports the measure making its way through the legislative process. The Governor came into office last year in November.

He has been calling for the creation of a regulatory body like the Nevada Casino and Gaming Board for the cannabis industry. To this end, he has set up an advisory panel to study and advise him about the best way to form a Cannabis Compliance Board.

The cannabis industry has been booming from 2017 when the first recreational sales were made. For example, recreational sales totaled $425 million in 2017, and this figure shot up to $884 million in the final six months of 2018.

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) can only ask that the misunderstandings about the licensing process should be cleared quickly so that all efforts can be concentrated on serving the people of Nevada.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Federally Grown Cannabis is Closer to Hemp than Commercially Available Cannabis, Study Finds

According to newly published research, the research-grade cannabis sourced from the only federally licensed cultivator (Mississippi University) is closer to hemp than the commercially available cannabis in the states where cannabis is legal.

The findings of this research bring into question the outcomes of the marijuana studies which have been conducted using the cannabis from the Mississippi farm. Do the results really help researchers to understand the real-world effects of cannabis?

Earlier research had demonstrated that the marijuana grown at the University of Mississippi using funds obtained from NIDA (National Institutes on Drug Abuse) had lower concentrations of THC and CBD when compared to the cannabis products that are commercially available.

However, the researchers from the University of Northern Colorado wanted to go a step further and compare the genetic composition of the federally-approved cannabis and what is on the market in states where cannabis is legal.

The researchers therefore obtained about 49 samples of hemp and cannabis taken from what is on the market and what NIDA avails to federally-approved research teams. The samples included sativa, indica and hybrid varieties of marijuana currently available on the market.

After analyzing these samples, the research team was surprised to find that the cannabis supplied by NIDA differed so much from what was on the market. The research-grade cannabis proved to be genetically closer to hemp rather than being similar to the cannabis consumers were accessing legally.

This outcome provides food for thought when one is thinking about using cannabis from NIDA to do research. If the research is focused on THC or CBD as standalone components, then the cannabis from Mississippi University can suffice.

However, if the study is intended to understand what effects cannabis has on the patients or recreational users, then the NIDA products aren’t appropriate since their use won’t mirror what people are consuming.

The findings of this Colorado study provide more momentum to the calls for expanding the federally-approved cultivators of research-grade cannabis in the U.S. While calls for interested parties to cultivate cannabis for research purposes were published, the Department of Justice has been very slow in processing the applications, so Mississippi University is still the sole federal source of cannabis for research purposes.

William Barr, the new U.S. Attorney General, has promised to look into the matter and take the necessary steps. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) hope that the research from the University of Northern Colorado triggers a sense of urgency in bringing more cultivators on board so that researchers can access cannabis of the right quality.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why Ohioans Aren’t Rushing to Buy Medical Cannabis

Medical cannabis has been available in Ohio for about three months now, but the latest data shows that the 20,000 people registered on the program haven’t displayed much eagerness to buy all the cannabis available at dispensaries. Here are some reasons that could explain this lack of buyer enthusiasm.

High Product Prices

One major concern for Ohio medical cannabis patients is the high prices being levied for medical cannabis products. On average, an ounce of cannabis costs $470. This is twice the cost of medical cannabis in Michigan.

Why is Michigan significant in this case? Patients from Ohio and other states can use their medical cannabis cards to buy medical marijuana in Michigan. It is therefore regrettable that the products in Ohio are so expensive.

This high cost can be attributed to the high licensing fees levied, as well as the rigid product packaging and testing requirements imposed by the state.

Dispensaries Aren’t Evenly Distributed

Ohio licensed 56 dispensaries. So far, only nine have opened their doors to patients. Unfortunately, all those nine are found on the Eastern side of the state.

Patients must therefore drive for several hours in order to find a dispensary and buy the products they need. Obviously, not many of the patients have felt the urge to endure those long drives.

Sales may therefore remain lukewarm until more dispensaries open closer to the patients who need the products available.

Unfavorable Possession Rules

Another major factor that can explain why patients aren’t buying as much medical cannabis as the state would expect is that the rules restrict a patient to just 90-days’ worth of cannabis. However, the clock starts ticking on those 90 days from the time you get your prescription from a doctor.

This means that every day you take without buying the maximum amount of cannabis allowed reduces the quantity that you will buy when you eventually visit a dispensary.

For example, a patient who goes to a dispensary 60 days after getting their prescription can only buy medical cannabis that can last a maximum of 30 days.

Furthermore, the high cost of cannabis means that patients may find it hard to buy a large amount of cannabis during one visit to a dispensary.

A Limited Range of Products

The law bars patients from smoking medical marijuana. However, only dried flower is currently available in the dispensaries that have so far opened.

This means that patients who want cannabis oil, tinctures, patches, lotions and edibles cannot spend any money on cannabis products until what they want is available.

All these issues show that the medical marijuana program has gotten off to a rocky start. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) hope that the medical cannabis program matures quickly so that each patient can get what they want at an affordable cost.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Complaints about the Minnesota Medical Cannabis Task Force Increase

When Minnesota legalized medical cannabis in 2014, a task force was established to evaluate the medical cannabis program and report back to the state. However, numerous complaints about the operation and effectiveness of this task force have arisen.

Representatives of patients, law enforcement agencies, the medical community, lawmakers and other stakeholders make up this task force. The task force is mandated to scrutinize patient access to the medical marijuana program, the affordability of the products and any other issue connected to medical cannabis.

However, the task force appears to have been doomed right from its very inception. For example, the law establishing this entity wasn’t very clear on the exact duties of the task force.

Consequently, some of its members thought that the task force would assess the conditions that people wanted to be added to the list of qualifying conditions and then make recommendations on the same while other members didn’t think the task force had that authority.

Additionally, the composition of the task force appears not to be conducive for the group to do its work. This is because the task force has members who have divergent views about the appropriateness of having a medical cannabis program in the state.

Such divergent views of the proponents and opponents of the medical marijuana program create a lot of tension during meetings, so it is hard for the members to agree on anything.

As if the issues above weren’t bad enough, the task force rarely meets. For example, the last meeting they held was in 2017. It is nearly two years since they held a meeting!

Even the meetings that have been convened haven’t been well attended. Denis Flaherty, the ED of the Minnesota Police and Peace Officers Association, revealed as much when he decided to resign his membership on the task force.

He said that being on the task force was “a waste of my time” due to the poor attendance and the lack of impact that the meetings were having.

Because of the lack of impact by the task force, medical marijuana remains very expensive (and many patients have resorted to the black market).

These complaints about the task force haven’t gone unnoticed by the powers that be in the state. For example, Rep. Heather Edelson has drafted a bill to clarify how often the task force should meet, and the specific issues they should consider during that annual meeting.

Gov. Tim Walz also acknowledged that there were frustrations with the task force. He revealed that he was considering recreating the group into a new one that will consider the legalization of recreational marijuana in addition to assessing the medical cannabis program.

It seems there is all round consensus that something needs to be done to make the task force more useful. Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) call on all the concerned authorities to revisit the task force so that medical marijuana patients aren’t exposed to preventable inconveniences.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Idaho Police to Procure Equipment That Distinguishes Cannabis from Hemp

A committee of the Idaho State Assembly has approved funding so that the state police can buy the equipment needed to test whether a given plant is industrial hemp or marijuana. This plan comes after the police seized a semitrailer carrying what the arresting officer thought was marijuana while the driver and his employer insisted that the consignment contained hemp.

The owner of the cargo, Big Sky Scientific, tried to get a court order to compel the police to release the cargo since it was deteriorating rapidly as the police continues with its investigations. The company argued that it was now legal to grow hemp and transport it across state lines from the time President Trump signed the Farm Bill 2018 into law.

However, court declined to issue the court order since the state didn’t have a law prescribing how hemp could be grown. Furthermore, the court could not be certain that Big Sky Scientific had grown its “hemp” in accordance with the Farm Act 2018.

This case has captured headlines within and outside Idaho because it serves as an eye-opener of the kind of situations that law enforcement agencies are likely to face now that hemp is legal while marijuana remains illegal at the federal level.

This confusion is likely to arise because there is no difference in the physical characteristics of hemp and cannabis. It is therefore possible for someone to attempt to transport cannabis across state borders while passing it off as hemp. It is also likely that hemp cultivators will face a lot of inconveniences as they jump through hoops to prove that what they are cultivating or transporting isn’t marijuana.

The procurement of the testing equipment was initiated by some lawmakers (not the police department) who felt that it was unsustainable to keep sending samples to Kentucky each time a seizure or arrest was made by the police. The argument of the lawmakers makes sense, because Big Sky Scientific stands to lose its cargo due to the delays created by having to conduct tests outside the state yet the crop is highly perishable and cannot retain its quality while the legal issues are sorted out.

For now, the entire Assembly has to approve the $240,000 funding request before the spending proposals go to the state Senate for approval. Only then can the money be released to procure and install the testing equipment in the police testing facility. Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) call for the speedy procurement of the testing equipment so that additional problems can be avoided later on.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New York Prosecutor Drops Marijuana Charges

A group of 35 people in Erie County received an unexpected gift when John Flynn, the Erie County District Attorney, requested that a judge at the Buffalo City Court accept the prosecutor’s request to dismiss the low-level marijuana charges (misdemeanor charges) against the nearly three dozen people.

The judge agreed with the prosecutor, and the charges were dismissed. It should be noted that the 35 people weren’t present in court. Their warrants were still outstanding and they had missed their court appearances.

In effect, the prosecutor saw no need to continue hunting for those individuals over a substance that would soon be legal throughout the state.

The action taken by John Flynn means that going forward, the District Attorney will no longer be interested in prosecuting such low-level marijuana cases within the jurisdiction.

The Erie County District Attorney isn’t the first to take such action within the state. Flynn is following in the footsteps of the prosecutors in New York City.

The mayor of Buffalo city is also on record for ordering the police in the city to stop arresting people for low-level marijuana crimes, such as possession of small amounts of cannabis.

These actions by prosecutors and the elected leaders seem to acknowledge that while the legislative process to legalize cannabis hasn’t been concluded, the population has gone ahead and started consuming recreational cannabis to such a high degree that it would be hard to clamp down on all of those users.

There is also widespread agreement across the state regarding the need to legalize marijuana for adult-use. Only law enforcement agencies and some members of the medical field still have reservations about adult-use marijuana.

The other disagreements are largely about how the industry will be regulated and where the taxes collected from cannabis will be spent.

For example, sections of lawmakers want the taxes collected from the recreational cannabis sector to be earmarked for revamping the dilapidated infrastructure in the state, such as the aging subway system.

However, others want a large portion of the cannabis taxes to be spent in the impoverished communities that bore the brunt of the war against drugs. The legislators in this school of thought have even threatened to vote against legalization if the law doesn’t stipulate what fraction of the marijuana taxes will go to the underprivileged communities in the inner cities.

What should be applauded in the meantime is the proactive step taken by the prosecutors to stop going after people who commit low-level marijuana infractions as the politicians are hashing out a law to legalize adult-use cannabis. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) are hoping that the lawmakers put the interests of New Yorkers first so that the best law is made for that jurisdiction.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com